Answers are grounded in this paper and cite their sources.
These results emphasize the clinical importance of anti-CADM-140/MDA5 antibody levels to predict outcomes of RP-ILD as well as to monitor disease activity in patients with DM and RP-ILD.
No takes yet. Share an insight, caveat, or question.
Sato et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: